250 related articles for article (PubMed ID: 30216603)
1. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG.
Wawrzycki B; Krasowska D; Pietrzak A; Szumilo J; Blazowski L; Pietraszek-Mamcarz J; Lotti T
Dermatol Ther; 2018 Sep; 31(5):e12635. PubMed ID: 30216603
[TBL] [Abstract][Full Text] [Related]
2. Postvaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin.
Ister M; Pouessel G; Ythier H; Catteau B; Carpentier O
Pediatr Dermatol; 2014; 31(4):e94-5. PubMed ID: 24916151
[TBL] [Abstract][Full Text] [Related]
3. Infantile bullous pemphigoid following vaccination.
Guerra L; Pedicelli C; Fania L; De Luca N; Condorelli AG; Mazzanti C; Di Zenzo G
Eur J Dermatol; 2018 Oct; 28(5):708-710. PubMed ID: 30325317
[No Abstract] [Full Text] [Related]
4. [Bullous pemphigoid in an infant after vaccination].
Mérida C; Martínez-Escribano JA; Frías JF; Sánchez-Pedreño P; Corbalán R
Actas Dermosifiliogr; 2005 May; 96(4):255-7. PubMed ID: 16476379
[TBL] [Abstract][Full Text] [Related]
5. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
Xiao T; Li B; Wang YK; He CD; Chen HD
J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
[TBL] [Abstract][Full Text] [Related]
6. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
[TBL] [Abstract][Full Text] [Related]
7. [Infantile bullous pemphigoid developing after hexavalent, meningococcal and pneumococcal vaccinations].
Valdivielso-Ramos M; Velázquez D; Tortoledo A; Hernanz JM
An Pediatr (Barc); 2011 Sep; 75(3):199-202. PubMed ID: 21676664
[TBL] [Abstract][Full Text] [Related]
8. Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review.
de la Fuente S; Hernández-Martín Á; de Lucas R; González-Enseñat MA; Vicente A; Colmenero I; González-Beato M; Suñol M; Torrelo A
Pediatr Dermatol; 2013; 30(6):741-4. PubMed ID: 24125034
[TBL] [Abstract][Full Text] [Related]
9. Childhood bullous pemphigoid developed after the first vaccination.
Baykal C; Okan G; Sarica R
J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):348-50. PubMed ID: 11174412
[TBL] [Abstract][Full Text] [Related]
10. Infantile Bullous Pemphigoid Treated Using Intravenous Immunoglobulin: Case Report and Review of the Literature.
Tekin B; Yücelten AD
Pediatr Dermatol; 2015; 32(5):723-6. PubMed ID: 26119800
[TBL] [Abstract][Full Text] [Related]
11. Optic neuritis following diphtheria, tetanus, pertussis, and inactivated poliovirus combined vaccination: a case report.
O'Brien P; Wong RW
J Med Case Rep; 2018 Nov; 12(1):356. PubMed ID: 30497512
[TBL] [Abstract][Full Text] [Related]
12. Infantile bullous pemphigoid successfully treated with intravenous immunoglobulin therapy.
Watanabe T; Hara S; Muto J; Watanabe D; Akiyama M
Clin Exp Dermatol; 2017 Jul; 42(5):576-578. PubMed ID: 28543802
[No Abstract] [Full Text] [Related]
13. Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy.
Sugawara N; Nagai Y; Matsushima Y; Aoyama K; Ishikawa O
J Am Acad Dermatol; 2007 Dec; 57(6):1084-9. PubMed ID: 17889964
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
15. Bullous pemphigoid treated with intravenous immunoglobulin.
Tuchinda P; Ritchie S; Gaspari AA
Cutis; 2014 May; 93(5):264-8. PubMed ID: 24897141
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
17. High-dose methylprednisolone in the treatment of bullous pemphigoid.
Siegel J; Eaglstein WH
Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
[TBL] [Abstract][Full Text] [Related]
18. Acquired hemophilia associated with bullous pemphigoid: a case report.
Qiu X; Zhang G; Xiao R; Zhang J; Zhou Y; Li G; Yan K; Lu Q
Int J Clin Exp Pathol; 2012; 5(1):102-4. PubMed ID: 22295154
[TBL] [Abstract][Full Text] [Related]
19. Refractory bullous pemphigoid with fatal outcome in a young patient.
Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
[No Abstract] [Full Text] [Related]
20. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA; King J; Law B; Mills E; Willems P
Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
